Chen Chen
For more than 15 years, Chen has served as a trusted adviser to early- to clinical-stage life sciences companies, investors, and research organizations, leveraging his strong technical background in biology and chemistry to optimize IP strategies for growth.
Chen’s business-minded approach helps clients throughout their lifecycles develop and implement IP strategies that align with clients’ visions for innovations in small molecule pharmaceuticals, antibody or nucleotide drugs, gene and cell therapies, formulations, and medical devices.
I provide IP solutions that scale with your company, helping your core innovations power growth at every inflection point."
Chen carefully positions clients for what’s next: from IP framework and strategy, patentability, FTO, and opinion work to series financings, licensing and collaboration, product commercialization, IPOs, and transactional IP due diligence.
Leveraging his extensive experience in financing, licensing, and other transactions, Chen sees around corners to help clients identify and address possible “pain points” in advance of negotiations.
With his strategic perspective and approach, Chen also guides clients through the competitive landscape to proactively develop IP strategies that minimize potential risks.
A native Mandarin speaker, Chen collaborates with colleagues to help clients with cross-border IP strategies, particularly in transactions involving China.
Recognition
- Image
Lawdragon2026Recognized as one of the 500 Leading Global IP Lawyers